Interleukin-1 Receptor Antagonist in Inflammatory Exudate Cells of Rabbits. Production, Purification and Determination of Primary Structure
Overview
Affiliations
A rabbit interleukin-1 (IL-1) inhibitor in inflammatory peritoneal exudate cells was purified to apparent homogeneity. This inhibitor was extracted from exudate cells of the 24-hr stage of casein-induced peritoneal inflammation and purified using isoelectrofocusing (IEF), gel filtration, followed in this order by high-performance liquid chromatography (HPLC) steps with hydroxylapatite and anionic ion exchanger. The purified factor showed a single band on silver-stained SDS-PAGE. This molecule of MW 19,000 and pI 5.5 inhibited the binding of both IL-1 alpha and beta to receptors on a thymoma cell line, EL-4 and a B-cell line, 70Z/3. We determined its primary structure by a combination of peptide chemistry and molecular cloning. The inhibitor was synthesized as a precursor composed of 177 amino acids and was processed to a mature molecule of 143 amino acids. The N-terminal amino acid of the mature inhibitor was N-acetyl-methionine residue. The deduced amino acid sequence of the inhibitor showed a 77% homology to the human IL-1 receptor antagonist (IL-1Ra) and essentially the same mode of action as seen with human IL-1Ra. We consider that this inhibitor is a rabbit counterpart of human IL-1Ra, although there are differences with respect to the molecular structure; the N-terminus of the mature rabbit IL-1Ra at a position of nine amino acids downstream from that of human IL-1Ra.
Fukumoto T, Matsukawa A, Ohkawara S, Takagi K, Yoshinaga M Inflamm Res. 1996; 45(9):479-85.
PMID: 8891760 DOI: 10.1007/BF02252320.
Kadota J, Matsubara Y, Ishimatsu Y, Ashida M, Abe K, Shirai R Clin Exp Immunol. 1996; 103(3):461-6.
PMID: 8608647 PMC: 2200364. DOI: 10.1111/j.1365-2249.1996.tb08303.x.
Matsukawa A, Ohkawara S, Maeda T, Takagi K, Yoshinaga M Clin Exp Immunol. 1993; 93(2):206-11.
PMID: 8348745 PMC: 1554844. DOI: 10.1111/j.1365-2249.1993.tb07967.x.
Role of interleukin-1 in the pathogenesis of experimental shigellosis.
Sansonetti P, Arondel J, Cavaillon J, Huerre M J Clin Invest. 1995; 96(2):884-92.
PMID: 7635983 PMC: 185275. DOI: 10.1172/JCI118135.